Nano imaging/treatment agent shows promise
This article was originally published in Clinica
Kereos' ultra-targeted nanoparticle technology that can simultaneously deliver a diagnostic imaging agent and drug - allowing both detection and treatment of a disease at the same time - has shown promise in an early study.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.